Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2017 Nov;96(45):e8573.
doi: 10.1097/MD.0000000000008573.

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

Affiliations
Comparative Study

Treatment of hypermyoglobinemia after CRS + HIPEC for patients with peritoneal carcinomatosis: A retrospective comparative study

Gang Liu et al. Medicine (Baltimore). 2017 Nov.

Abstract

This retrospective comparative study aims to explore the time courses of serum myoglobin (Mb) changes, and summarize our experience in treating patients with hypermyoglobinemia after cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).This study covered 60 patients with peritoneal carcinomatosis treated with CRS + HIPEC as the study group, and another 25 cancer patients treated with conventional extensive surgery without HIPEC as the control group from February to October 2016. In the study group, patients with postoperative hypermyoglobinemia were on a comprehensive treatment regimen consisting intravenous injection of sodium bicarbonate solution according to the Mb level. In the control group, patients were recorded and treated with the same regimen except for special sodium bicarbonate solution. The preoperative and postoperative serum Mb, blood urine nitrogen (BUN), and creatinine (Cr) levels were evaluated.There were no significantly difference between the 2 groups in serum Mb, BUN, and Cr levels before surgery. Postoperative serum Mb levels were elevated in both groups and significantly higher on postoperative 0 to 2 days (P < .05) in the study group than the control group. The peak value of serum Mb levels (426.65 ± 108.386 μg/L) occurred on the surgery day. The serum Mb change rate was much bigger in the study group than the control group. Serum BUN levels in both groups revealed a slow increase during the early postoperative period and were significantly lower in the study group than the control group on days 1 and 2. The serum Cr levels were similar and stable between the 2 groups after surgery. The serum Cr change rates changed synchronously with same tendency in both groups, and on postoperative day 1 the increase rate was bigger in the control group than the study group.Hypermyoglobinemia is a common and prominent lab abnormality after CRS + HIPEC, and serum Mb levels could be an early and sensitive indicator for dramatic disturbances in the internal milieu after CRS + HIPEC. Adequate treatment with sodium bicarbonate could accelerate the reduction in serum Mb levels and reduce the risk for major organ damages.

PubMed Disclaimer

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Comparison in perioperative serum Mb levels between the study group and the control group. Serum Mb levels were similar between the 2 groups before surgery (day −1). Immediately after surgery, the study group had significantly higher serum Mb levels than the control groups for 3 days (days 0, 1, and 2). On postoperative days 3 and 4, there were no significant differences in serum Mb levels between the 2 groups.
Figure 2
Figure 2
Serum Mb level changes in the study group and the control group. (A) The serum Mb curves showed that the study group had much bigger increases and decreases than the control group. (B) In terms of serum Mb change rates, at each time point, the serum Mb change rates were much bigger in the study group than the control group.
Figure 3
Figure 3
Comparison in perioperative serum BUN levels between the study group and the control group. Serum BUN levels were similar between the 2 groups before surgery (day −1) and surgery day (day 0). After surgery, the study group had significantly lower serum BUN levels than the control groups for 2 days (days 1 and 2). On postoperative days 3 and 4, there were no significant differences in serum BUN levels between the 2 groups. BUN = blood urine nitrogen.
Figure 4
Figure 4
Serum BUN level changes in the study group and the control group. (A) The serum BUN curves showed that both groups had a slow increase during the early postoperative period. (B) In terms of serum BUN change rates, at each time point, the serum BUN change rates increased synchronously but decreased slowly in the study group than the control group after surgery. BUN = blood urine nitrogen.
Figure 5
Figure 5
Comparison in perioperative serum Cr levels between the study group and the control group. Serum Cr levels were similar between the 2 groups before surgery (day −1) and postoperation days (days 0–4).
Figure 6
Figure 6
Serum Cr level changes in the study group and the control group. (A) The serum Cr curves showed that both groups had a similar and stable serum Cr levels during the perioperative period. (B) In terms of serum Cr change rates, at each time point, the serum Cr change rates changed synchronously with same tendency in both groups.

Similar articles

Cited by

References

    1. Li Y, Zhou YF, Liang H, et al. Chinese expert consensus on cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal malignancies. World J Gastroenterol 2016;22:6906–16. - PMC - PubMed
    1. Chua TC, Moran BJ, Sugarbaker PH, et al. Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. J Clin Oncol 2012;30:2449–56. - PubMed
    1. Verwaal VJ, Van Ruth S, De Bree E, et al. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737–43. - PubMed
    1. Spiliotis J, Halkia E, Lianos E, et al. Cytoreductive surgery and HIPEC in recurrent epithelial ovarian cancer: a prospective randomized phase III study. Ann Surg Oncol 2015;22:1570–5. - PubMed
    1. Sun JH, Ji ZH, Yu Y, et al. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy to treat advanced/recurrent epithelial ovarian cancer: results from a retrospective study on prospectively established database. Transl Oncol 2016;9:130–8. - PMC - PubMed

Publication types

MeSH terms